• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将固有免疫与慢性抗体介导的同种异体移植物排斥反应联系起来。

Linking innate immunity and chronic antibody-mediated allograft rejection.

机构信息

Department of Surgery, Division of Transplant, University of Colorado Aurora, Denver, Colorado.

Department of Medicine, Division of Pulmonary, Critical Care & Sleep Medicine, University of Florida, Gainesville, Florida, USA.

出版信息

Curr Opin Organ Transplant. 2019 Dec;24(6):694-698. doi: 10.1097/MOT.0000000000000708.

DOI:10.1097/MOT.0000000000000708
PMID:31599762
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7371248/
Abstract

PURPOSE OF REVIEW

To summarize recent findings linking donor-specific antibodies with innate immunity resulting in chronic allograft rejection.

RECENT FINDINGS

Studies in recent years highlight the significance of donor-specific antibodies (DSA) in both acute and chronic allograft rejection. Since chronic rejection is the leading cause of graft failure, this review centers on the contribution of three areas of innate immunity of particular recent focus: complement, NK cells, and macrophages. Recent advances indicate the diverse roles that complement components play both in directly initiating allograft injury and indirectly by contributing to enhanced alloreactivity. NK cells also have emerged as an additional innate response that directly links DSA with chronic graft injury. Finally, recent studies identify alternatively activated macrophages as an additional arm of innate immunity contributing to chronic allograft rejection.

SUMMARY

Chronic allograft rejection involves a significant contribution of DSA and differing pathways of the innate immune system. However, key issues remain unresolved. First, it is not always clear which of these varied sources of innate immunity contributing to chronic rejection may be antibody dependent. Moreover, it is not yet clear if these innate pathways represent independent routes that contribute to chronic rejection or rather act in concert to mediate allograft injury.

摘要

目的综述

总结近年来将供体特异性抗体与先天免疫联系起来导致慢性移植物排斥的研究进展。

最近的发现

近年来的研究强调了供体特异性抗体(DSA)在急性和慢性移植物排斥中的重要性。由于慢性排斥是移植物失功的主要原因,因此本综述集中讨论了先天免疫三个近期特别关注领域的贡献:补体、NK 细胞和巨噬细胞。最近的进展表明,补体成分在直接引发移植物损伤和通过增强同种反应性间接发挥作用方面具有多种作用。NK 细胞也已成为与慢性移植物损伤直接相关的另一种先天反应。最后,最近的研究确定了另一种先天免疫途径——M2 型巨噬细胞,其在慢性移植物排斥中也发挥作用。

总结

慢性移植物排斥涉及 DSA 和先天免疫系统不同途径的显著贡献。然而,仍有一些关键问题尚未解决。首先,尚不清楚哪些不同的先天免疫来源可能与慢性排斥相关。此外,尚不清楚这些先天途径是否代表独立的导致慢性排斥的途径,还是协同作用以介导移植物损伤。

相似文献

1
Linking innate immunity and chronic antibody-mediated allograft rejection.将固有免疫与慢性抗体介导的同种异体移植物排斥反应联系起来。
Curr Opin Organ Transplant. 2019 Dec;24(6):694-698. doi: 10.1097/MOT.0000000000000708.
2
M2 Macrophages Serve as Critical Executor of Innate Immunity in Chronic Allograft Rejection.M2 巨噬细胞在慢性移植排斥反应中的固有免疫中充当关键执行者。
Front Immunol. 2021 Mar 17;12:648539. doi: 10.3389/fimmu.2021.648539. eCollection 2021.
3
Recent advances in allograft vasculopathy.同种异体移植血管病变的最新进展
Curr Opin Organ Transplant. 2017 Feb;22(1):1-7. doi: 10.1097/MOT.0000000000000370.
4
Chronic allograft dysfunction: a model disorder of innate immunity.慢性移植器官功能障碍:一种先天性免疫的典型病症。
Biomed J. 2013 Sep-Oct;36(5):209-28. doi: 10.4103/2319-4170.117622.
5
In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.在自然杀伤细胞激活缺失的情况下,供体特异性抗体介导慢性而非急性肾移植排斥反应。
Kidney Int. 2019 Feb;95(2):350-362. doi: 10.1016/j.kint.2018.08.041. Epub 2018 Nov 29.
6
Adaptive features of innate immune cells and their relevance to graft rejection.固有免疫细胞的适应性特征及其与移植物排斥的相关性。
Curr Opin Organ Transplant. 2019 Dec;24(6):664-669. doi: 10.1097/MOT.0000000000000707.
7
Natural Killer Cells: Critical Effectors During Antibody-mediated Rejection of Solid Organ Allografts.自然杀伤细胞:在抗体介导的实体器官同种异体移植排斥反应中的关键效应细胞。
Transplantation. 2021 Feb 1;105(2):284-290. doi: 10.1097/TP.0000000000003298.
8
Computer-assisted topological analysis of renal allograft inflammation adds to risk evaluation at diagnosis of humoral rejection.计算机辅助的肾移植炎症拓扑分析增加了体液排斥诊断时的风险评估。
Kidney Int. 2017 Jul;92(1):214-226. doi: 10.1016/j.kint.2017.01.011. Epub 2017 Mar 18.
9
Innate immunity in ischemia-reperfusion injury and graft rejection.缺血再灌注损伤和移植物排斥中的固有免疫。
Curr Opin Organ Transplant. 2019 Dec;24(6):687-693. doi: 10.1097/MOT.0000000000000709.
10
Clinical Significance of HLA-DQ Antibodies in the Development of Chronic Antibody-Mediated Rejection and Allograft Failure in Kidney Transplant Recipients.HLA-DQ抗体在肾移植受者慢性抗体介导性排斥反应及移植肾失功发生中的临床意义
Medicine (Baltimore). 2016 Mar;95(11):e3094. doi: 10.1097/MD.0000000000003094.

引用本文的文献

1
Tocilizumab-Based Treatment of Microvascular Inflammation in Kidney Transplant Recipients: A Retrospective Study.托珠单抗治疗肾移植受者微血管炎症:一项回顾性研究。
Transpl Int. 2025 May 16;38:14502. doi: 10.3389/ti.2025.14502. eCollection 2025.
2
Anti-Human Leukocyte Antigen Antibody Detection from Terasaki's Humoral Theory to Delisting Strategies in 2024.从寺崎的体液理论到2024年退市策略的抗人白细胞抗原抗体检测
Int J Mol Sci. 2025 Jan 13;26(2):630. doi: 10.3390/ijms26020630.
3
HDAC6 inhibition: a significant potential regulator and therapeutic option to translate into clinical practice in renal transplantation.组蛋白去乙酰化酶 6 抑制:有望转化为肾移植临床实践的重要潜在调控因子和治疗选择。
Front Immunol. 2023 Jul 21;14:1168848. doi: 10.3389/fimmu.2023.1168848. eCollection 2023.
4
Bringing Clarity to the Murky Problem of Cardiac Allograft Vasculopathy.为心脏同种异体移植血管病变这一棘手问题带来清晰认识。
Am J Pathol. 2022 Jul;192(7):986-989. doi: 10.1016/j.ajpath.2022.05.002. Epub 2022 May 14.
5
VCAM1 expression in the myocardium is associated with the risk of heart failure and immune cell infiltration in myocardium.心肌中 VCAM1 的表达与心力衰竭风险和心肌中免疫细胞浸润相关。
Sci Rep. 2021 Sep 30;11(1):19488. doi: 10.1038/s41598-021-98998-3.
6
Designing biomaterials for the modulation of allogeneic and autoimmune responses to cellular implants in Type 1 Diabetes.设计生物材料以调节 1 型糖尿病中细胞移植物的同种异体和自身免疫反应。
Acta Biomater. 2021 Oct 1;133:87-101. doi: 10.1016/j.actbio.2021.05.039. Epub 2021 Jun 5.
7
The natural killer cell activating receptor, NKG2D, is critical to antibody-dependent chronic rejection in heart transplantation.自然杀伤细胞激活受体 NKG2D 对于心脏移植中的抗体依赖性慢性排斥反应至关重要。
Am J Transplant. 2021 Nov;21(11):3550-3560. doi: 10.1111/ajt.16690. Epub 2021 Jun 17.
8
CHBP induces stronger immunosuppressive CD127 M-MDSC via erythropoietin receptor.CHBP 通过促红细胞生成素受体诱导更强的免疫抑制性 CD127 M-MDSC。
Cell Death Dis. 2021 Feb 12;12(2):177. doi: 10.1038/s41419-021-03448-7.
9
Single cell transcriptomics of mouse kidney transplants reveals a myeloid cell pathway for transplant rejection.鼠肾移植的单细胞转录组学揭示了一种用于移植排斥的髓样细胞途径。
JCI Insight. 2020 Oct 15;5(20):141321. doi: 10.1172/jci.insight.141321.

本文引用的文献

1
Complement Membrane Attack Complexes Assemble NLRP3 Inflammasomes Triggering IL-1 Activation of IFN-γ-Primed Human Endothelium.补体膜攻击复合物组装 NLRP3 炎性小体,触发 IFN-γ 预激活的人内皮细胞中的 IL-1 激活。
Circ Res. 2019 Jun 7;124(12):1747-1759. doi: 10.1161/CIRCRESAHA.119.314845. Epub 2019 Apr 22.
2
ZFYVE21 is a complement-induced Rab5 effector that activates non-canonical NF-κB via phosphoinosotide remodeling of endosomes.ZFYVE21 是一种补体诱导的 Rab5 效应物,通过内体磷酸肌醇重塑激活非经典 NF-κB。
Nat Commun. 2019 May 21;10(1):2247. doi: 10.1038/s41467-019-10041-2.
3
C5b9 Deposition in Glomerular Capillaries Is Associated With Poor Kidney Allograft Survival in Antibody-Mediated Rejection.C5b9 在肾小球毛细血管中的沉积与抗体介导的排斥反应中不良的肾移植存活率相关。
Front Immunol. 2019 Mar 8;10:235. doi: 10.3389/fimmu.2019.00235. eCollection 2019.
4
Factors at de novo donor-specific antibody initial detection associated with allograft loss: a multicenter study.与移植物丢失相关的初次检测到供体特异性抗体的因素:一项多中心研究。
Transpl Int. 2019 May;32(5):502-515. doi: 10.1111/tri.13395. Epub 2019 Feb 8.
5
C5aR1 regulates T follicular helper differentiation and chronic graft-versus-host disease bronchiolitis obliterans.C5aR1 调节 T 滤泡辅助细胞分化和慢性移植物抗宿主病细支气管炎性闭塞。
JCI Insight. 2018 Dec 20;3(24):124646. doi: 10.1172/jci.insight.124646.
6
Absence of recipient C3aR1 signaling limits expansion and differentiation of alloreactive CD8 T cell immunity and prolongs murine cardiac allograft survival.缺乏受体 C3aR1 信号会限制同种异体反应性 CD8 T 细胞免疫的扩增和分化,并延长小鼠心脏移植物的存活时间。
Am J Transplant. 2019 Jun;19(6):1628-1640. doi: 10.1111/ajt.15222. Epub 2019 Jan 14.
7
In the absence of natural killer cell activation donor-specific antibody mediates chronic, but not acute, kidney allograft rejection.在自然杀伤细胞激活缺失的情况下,供体特异性抗体介导慢性而非急性肾移植排斥反应。
Kidney Int. 2019 Feb;95(2):350-362. doi: 10.1016/j.kint.2018.08.041. Epub 2018 Nov 29.
8
Antibody-Mediated Rejection of Solid-Organ Allografts.抗体介导的实体器官同种异体移植排斥反应
N Engl J Med. 2018 Sep 20;379(12):1150-1160. doi: 10.1056/NEJMra1802677.
9
Pretransplant C3d-Fixing Donor-Specific Anti-HLA Antibodies Are Not Associated with Increased Risk for Kidney Graft Failure.移植前 C3d 固定的供体特异性抗 HLA 抗体与增加肾移植失败风险无关。
J Am Soc Nephrol. 2018 Sep;29(9):2279-2285. doi: 10.1681/ASN.2018020205. Epub 2018 Jul 26.
10
Complement-activating donor-specific anti-HLA antibodies and solid organ transplant survival: A systematic review and meta-analysis.补体激活的供体特异性抗 HLA 抗体与实体器官移植存活:系统评价和荟萃分析。
PLoS Med. 2018 May 25;15(5):e1002572. doi: 10.1371/journal.pmed.1002572. eCollection 2018 May.